• MangioneDontMiss@feddit.nl
    link
    fedilink
    English
    arrow-up
    93
    arrow-down
    2
    ·
    1 year ago

    40 dollars in low income countries. 28,000 dollars in the united states. The drug is made in the united states.

    WTF.

    • SaveTheTuaHawk@lemmy.ca
      link
      fedilink
      English
      arrow-up
      44
      arrow-down
      4
      ·
      1 year ago

      Makes you wonder if Trump has a point.

      But thanks to RFK and Trump, there will be no more drugs like this in the future. Gilead did the trials, but 95% of the effort behind this was NIH funded. We can’t even guess how many game changing drugs have been cut in 2025.

      • AA5B@lemmy.world
        link
        fedilink
        English
        arrow-up
        25
        arrow-down
        2
        ·
        1 year ago

        As always Trump completely misunderstands the situation. Yes there’s a point in how exepnsive drugs are in the us, especially relative to other countries. But whether it’s manufactured in the us has almost nothing to do with it.

        The problem is recovering all the development costs from American patients, and more recently just charging what they think the market will bear. We have to fix the complex maze of healthcare and all the levels of profiteering, we have to fix how development costs can be recovered and most of all we need to fix charging what the market will bear. Has everyone already forgotten the outcry over insulin a few years ago. A ceo who should be in jail decided to start charging ten or twenty times the cost, because he could, because us patients are a captive market. Then got away with saying “some of you can use these coupons….”. There’s definitely a point where exploitive business practices have crossed the line and should be considered criminal acts

        • SaveTheTuaHawk@lemmy.ca
          link
          fedilink
          English
          arrow-up
          3
          ·
          1 year ago

          Drug development in trials costs $120-200M. Upon approval, Pharma expects $15B +.

          They have proven they would rather a drug not save lives than offer lower profits.

        • kbobabob@lemmy.dbzer0.com
          link
          fedilink
          English
          arrow-up
          3
          ·
          1 year ago

          A hell of a lot of that is funded by tax payers. They don’t need to recoup money, they need to give the tax payers what they already paid for.

      • SaveTheTuaHawk@lemmy.ca
        link
        fedilink
        English
        arrow-up
        6
        ·
        1 year ago

        Pharmaceutical companies used to do basic research until the 90s. At this point, they are just banks who buy biotechs spun out from NIH research.

        Now that NIH is gone, the industry will atrophy within a decade. There will be no new drugs.

    • LaLuzDelSol@lemmy.world
      link
      fedilink
      English
      arrow-up
      6
      arrow-down
      18
      ·
      1 year ago

      I figured this would come up but you’ve gotta remember that drugs are expensive as hell to develop. And it just received US approval in June so it’s not like they have been sitting on this making money for years.

      • SaveTheTuaHawk@lemmy.ca
        link
        fedilink
        English
        arrow-up
        31
        arrow-down
        2
        ·
        1 year ago

        The cost of drug development is vastly overstated as an excuse. The reality is $100-200M, but pharma expects $14B++ in returns. Little of that goes back into basic research.

        The front end of costs was spent by the NIH, and after that was ended, Pharma is not taking up the slack. It’s not sustainable and pharma will die in a decade.

        • Dozzi92@lemmy.world
          link
          fedilink
          English
          arrow-up
          16
          arrow-down
          1
          ·
          1 year ago

          Yeah, a lot of these drug companies have ad budgets larger than the R&D budget, but any overhead is used to jack up the prices. I swear ads are sold at inflated prices for the sake of being able to sell high.

        • Gladaed@feddit.org
          link
          fedilink
          English
          arrow-up
          9
          arrow-down
          4
          ·
          1 year ago

          Just because development of a single drug costs not that much does not mean you don’t need to pay for failed drugs too. If many drugs die during trials someone gotta pay for that. Profitability is a better indicator for greed.

        • LaLuzDelSol@lemmy.world
          link
          fedilink
          English
          arrow-up
          4
          arrow-down
          1
          ·
          1 year ago

          I’d like to see some sources on those numbers, I couldn’t find any of that when I searched.